Market Research Life Sciences Market Research Pharmaceuticals Market Research Biopharmaceuticals Market Research

Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing

Best Price Guarantee Length Publisher Published Date SKU
from $4,950 390 Pages Fatpos Global November, 2023 FAGL18435234
Best Price Guarantee
Price from $4,950
Length 390 Pages
Publisher Fatpos Global
Published Date November, 2023
SKU FAGL18435234

Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032


Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

Biopharmaceutical Market size was USD 311.2 billion in 2021 and projected to grow from USD 376.2 billion in 2023 to USD 895.2 billion by 2032, exhibiting a CAGR of 10.1% during the forecast period.

Biopharmaceuticals are also referred as biologics or biologic drugs which are medical products obtained from biological sources like living organisms, proteins etc. Biopharmaceuticals are the drugs originated using biotechnology procedures and are important in modern healthcare. Biopharmaceuticals are also designed to target specific molecular characteristics of disease related to patients which is a customized treatment.

MARKET HIGHLIGHTS

Biopharmaceutical Market is expected to reach USD 895.2 billion, growing at a CAGR of 10.1% during forecast period owing to the increasing prevalence of chronic diseases and rising geriatric population which may boost the demand for growth of biopharmaceutical market. Biopharmaceuticals provide targeted therapies and have less side effects along with enhanced efficiency. The increasing research and development activities along with the usage growing usage of monoclonal antibodies in therapeutics of in vitro diagnostics is bolstering the growth of the Biopharmaceutical market.

Biopharmaceutical Market Segments:
  • Product Type
  • Purified Proteins
  • Recombinant Growth Factors
  • Recombinant Proteins
  • Recombinant Hormone
  • Synthetic Immunomodulatory
  • Monoclonal Antibodies
  • Vaccines
  • Other
  • Service
  • Custom Testing / Customer Proprietary Testing
  • Laboratory Testing
  • Compendial, and Multi Compendial Laboratory Testing
  • Raw Material Type
  • Active Pharmaceutical Ingredients (API)
  • Formulation Excipients
  • Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support
  • Application
  • Autoimmune Disorders
  • Metabolic Disorders
  • Oncology
  • Inflammatory and Infectious Diseases
  • Hormonal Disorders
  • Neurological Diseases
  • Cardiovascular Diseases
  • Other
MARKET DYNAMICS

Growth Drivers

Increasing Necessity of Biopharmaceuticals are Expected to Boost the Growth of the Market

Rising Investment in Healthcare is Expected to Boost the Growth of the Market

Restraint

Safety Issues May Restrain the Growth of the Market

Key Players
  • Amgen Inc.
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Lilly
  • Pfizer Inc.
  • Sanofi
  • Abbott
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Novo Nordisk A/S
  • bioMérieux
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Bayer AG
  • Biogen
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*


1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Biopharmaceutical Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Biopharmaceutical Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Biopharmaceutical Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Biopharmaceutical Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Biopharmaceutical Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product Type
11.3.1.1. Purified Proteins
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Recombinant Growth Factors
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Recombinant Proteins
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Recombinant Hormone
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Synthetic Immunomodulatory
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Monoclonal Antibodies
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Vaccines
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.8.Other
11.3.1.8.1.By Value (USD Million) 2022-2032F
11.3.1.8.2. Market Share (%) 2022-2032F
11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Service
11.3.2.1.Custom Testing / Customer Proprietary Testing
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Laboratory Testing
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Compendial, and Multi Compendial Laboratory Testing
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By Raw Material Type
11.3.3.1.Active Pharmaceutical Ingredients (API)
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Formulation Excipients
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.4. By Application
11.3.4.1.Autoimmune Disorders
11.3.4.1.1.By Value (USD Million) 2022-2032F
11.3.4.1.2. Market Share (%) 2022-2032F
11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.2. Metabolic Disorders
11.3.4.2.1. By Value (USD Million) 2022-2032F
11.3.4.2.2.Market Share (%) 2022-2032F
11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.3. Oncology
11.3.4.3.1. By Value (USD Million) 2022-2032F
11.3.4.3.2. Market Share (%) 2022-2032F
11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.4. Inflammatory and Infectious Diseases
11.3.4.4.1.By Value (USD Million) 2022-2032F
11.3.4.4.2. Market Share (%) 2022-2032F
11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.5. Hormonal Disorders
11.3.4.5.1.By Value (USD Million) 2022-2032F
11.3.4.5.2. Market Share (%) 2022-2032F
11.3.4.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.6. Neurological Diseases
11.3.4.6.1. By Value (USD Million) 2022-2032F
11.3.4.6.2.Market Share (%) 2022-2032F
11.3.4.6.3.Y-o-Y Growth (%) 2022-2032F
11.3.4.7. Cardiovascular Diseases
11.3.4.7.1. By Value (USD Million) 2022-2032F
11.3.4.7.2.Market Share (%) 2022-2032F
11.3.4.7.3.Y-o-Y Growth (%) 2022-2032F
11.3.4.8. Other
11.3.4.8.1.By Value (USD Million) 2022-2032F
11.3.4.8.2. Market Share (%) 2022-2032F
11.3.4.8.3. Y-o-Y Growth (%) 2022-2032F
12. North America Biopharmaceutical Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2.By Service
12.3.3.By Raw Material Type
12.3.4.By Application
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Biopharmaceutical Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2.By Service
13.3.3.By Raw Material Type
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Biopharmaceutical Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2.By Service
14.3.3.By Raw Material Type
14.3.4. By Application
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Biopharmaceutical Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2.By Service
15.3.3.By Raw Material Type
15.3.4.By Application
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Biopharmaceutical Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2.By Service
16.3.3.By Raw Material Type
16.3.4.By Application
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Amgen Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. AstraZeneca
18.3. Johnson & Johnson Private Limited
18.4.Lilly
18.5. Pfizer Inc.
18.6. Sanofi
18.7. Abbott
18.8.Novartis AG
18.9. F. Hoffmann-La Roche Ltd.
18.10.Novo Nordisk A/S
18.11.bioMérieux
18.12.Merck & Co., Inc.
18.13.Bristol-Myers Squibb Company
18.14.GlaxoSmithKline Plc
18.15.Bayer AG
18.16. Biogen
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation

$4,950
$6,150

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings